Epidemiology of Hepatocellular Carcinoma
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ferlay, 2001
Bosch, 2004, Primary liver cancer: worldwide incidence and trends, Gastroenterology, 127, S5, 10.1053/j.gastro.2004.09.011
2002
Lee, 1993, Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B-endemic area, Cancer, 72, 2564, 10.1002/1097-0142(19931101)72:9<2564::AID-CNCR2820720909>3.0.CO;2-#
Bosch, 1997, Global epidemiology of hepatocellular carcinoma, 13
Donato, 2002, Alcohol and Hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women, Am J Epidemiol, 155, 323, 10.1093/aje/155.4.323
Yu, 2001, Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men, J Natl Cancer Inst, 93, 1644, 10.1093/jnci/93.21.1644
1967
1977
1992
Hoel, 1993, Influence of death certificate errors on cancer mortality trends, J Natl Cancer Inst, 85, 1063, 10.1093/jnci/85.13.1063
Coleman, 2003, EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century, Ann Oncol, 14, V128, 10.1093/annonc/mdg756
Ries, 2004
Parkin, 1992, Studies of cancer in migrant populations: methods and interpretation, Rev Epidemiol Sante Publique, 40, 410
Hanley, 1995, Cancer mortality among Chinese migrants: a review, Int J Epidemiol, 24, 255, 10.1093/ije/24.2.255
Khlat, 1993, Cancer mortality in immigrants from the Near East in Australia, Rev Epidemiol Sante Publique, 41, 208
Bouchardy, 1994, Cancer moratlity among Chinese and South-East Asian migrants in France, Int J Cancer, 58, 638, 10.1002/ijc.2910580504
Fang, 1996, Cancer mortality of Chinese in New York City 1988–1992, Int J Epidemiol, 25, 907, 10.1093/ije/25.5.907
Grulich, 1992, Cancer mortality in African and Caribbean migrants to England and Wales, Br J Cancer, 66, 905, 10.1038/bjc.1992.383
McCredie, 1999, Cancer mortality in East and Southeast Asian migrants to New South Wales, Australia, 1975–1995, Br J Cancer, 79, 1277, 10.1038/sj.bjc.6690205
King, 1980, Cancer mortality among Chinese in the United States, J Natl Cancer Inst, 65, 1141
Rosenblatt, 1996, Liver cancer in Asian migrants to the United States and their descendants, Cancer Causes Control, 7, 345, 10.1007/BF00052940
Benhamiche, 1998, Time trends and age-period-cohort effects on the incidence of primary liver cancer in a well-defined French population: 1976–1995, J Hepatol, 29, 802, 10.1016/S0168-8278(98)80262-6
McGlynn, 2001, International trends and patterns of primary liver cancer, Int J Cancer, 94, 290, 10.1002/ijc.1456
Taylor-Robinson, 1997, Increase in primary liver cancer in the UK, 1979–94, Lancet, 350, 1142, 10.1016/S0140-6736(05)63789-0
Okuda, 1987, Changing incidence of hepatocellular carcinoma in Japan, Cancer Res, 47, 4967
El-Serag, 1999, Rising incidence of hepatocellular carcinoma in the United States, N Engl J Med, 340, 745, 10.1056/NEJM199903113401001
El Serag, 2003, The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update, Ann Intern Med, 139, 817, 10.7326/0003-4819-139-10-200311180-00009
Khan, 2002, Changing international trends in mortalitty rates for liver, biliary and pancreatic tumours, J Hepatol, 37, 806, 10.1016/S0168-8278(02)00297-0
Levi, 2004, Cancer mortality in Europe, 1995–1999, and overview of trends since 1960, Int J Cancer, 110, 155, 10.1002/ijc.20097
Patel, 2001, Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States, Hepatology, 33, 1353, 10.1053/jhep.2001.25087
Ribes, 2004, Time trends in incidence and mortality for chronic liver disease and liver cancer in the interval 1980–1997 in Catalonia, Spain, Eur J Gastroenterol Hepatol, 16, 865, 10.1097/00042737-200409000-00009
Prince, 1982, The risk of development of hepatocellular carcinoma in hepatitis B virus carrier in New York. A preliminary estimate using death-records matching, Hepatology, 2, 15
Dodd, 1987, Increased risk for lethal forms of liver disease among HBsAg-positive blood donors in the United States, J Virol Methods, 17, 81, 10.1016/0166-0934(87)90071-1
Hall, 1985, Mortality of hepatitis B positive blood donors in England and Wales, Lancet, 1, 91, 10.1016/S0140-6736(85)91976-2
Crook, 2003, Mortality of hepatitis B surface antigen-positive blood donors in England and Wales, Int J Epidemiol, 32, 118, 10.1093/ije/dyg039
Oshima, 1984, Follow-up study of HBsAg-positive blood donors with special reference to effect of drinking and smoking on development of liver cancer, Int J Cancer, 34, 775, 10.1002/ijc.2910340607
Sakuma, 1988, Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: a prospective study, Hepatology, 8, 1642, 10.1002/hep.1840080628
Sakuma, 1982, Prognosis of hepatitis B virus surface antigen carriers in relation to routine liver function tests: a prospective study, Gastroenterology, 83, 114, 10.1016/S0016-5085(82)80294-1
Iijima, 1984, A prospective cohort study of hepatitis B surface antigen carriers in a working population, Gann, 75, 571
Tokudome, 1987, Hepatocellular carcinoma among female japanese hepatitis b virus carriers, Hepatogastroenterol, 34, 246
Tokudome, 1988, Hepatocellular carcinoma among HBsAg positive blood donors in Fukuoka, Japan, Eur J Cancer Clin Oncol, 2, 235, 10.1016/0277-5379(88)90259-3
Beasley, 1981, Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22707 men in Taiwan, Lancet, ii, 1129, 10.1016/S0140-6736(81)90585-7
Beasley, 1988, Hepatitis B virus. The major etiology of hepatocellular carcinoma, Cancer, 61, 1942, 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J
Yang, 2002, Hepatitis B e antigen and the risk of hepatocellular carcinoma, N Engl J Med, 347, 168, 10.1056/NEJMoa013215
Tu, 1985, Hepatitis B virus and primary liver cancer on Chongming Island, People's Republic of China, J Natl Cancer Inst Monogr, 69, 213
Yeh, 1989, Hepatitis B virus, Aflatoxins, and hepatocellular carcinoma in Southern Guangxi, China, Cancer Res, 49, 2506
Ross, 1992, Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma, Lancet, 339, 943, 10.1016/0140-6736(92)91528-G
Evans, 2002, Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences, Cancer Epidemiol Biomarkers Prev, 11, 369
Alter, 2003, Epidemiology and prevention of hepatitis B, Semin Liver Dis, 23, 39, 10.1055/s-2003-37583
Evans, 1998, Geographic variations in viral load among Hepatitis B carriers with differing risks of hepatocellular carcinoma, Cancer Epidemiol Biomark Prev, 7, 559
Tang, 2004, Hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in chronic carriers, J Med Virol, 72, 35, 10.1002/jmv.10559
Fattovich, 2003, Natural history and prognosis of hepatitis B, Semin Liver Dis, 23, 47, 10.1055/s-2003-37590
Abdel-Aziz, 2000, Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence, Hepatology, 32, 111, 10.1053/jhep.2000.8438
Yoshizawa, 2002, Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future, Oncology, 62, 8, 10.1159/000048270
Okuda, 1991, Hepatitis C virus and hepatocellular carcinoma, 119
Wasley, 2000, Epidemiology of hepatitis C: geographic differences and temporal trends, Semin Liver Dis, 20, 1, 10.1055/s-2000-9506
Frank, 2000, The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt, Lancet, 355, 887, 10.1016/S0140-6736(99)06527-7
Okuda, 1997, Hepatitis C and hepatocellular carcinoma, 39
El-Serag, 2000, Risk factors for the rising rates of primary liver cancer in the United States, Arch Intern Med, 160, 3227, 10.1001/archinte.160.21.3227
Bosch, 2002, The epidemiology of primary liver cancer: global epidemiology, 1
Brechot, 2001, Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely “occult”?, Hepatology, 34, 194, 10.1053/jhep.2001.25172
Brechot, 1998, Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action, J Hepatol, 29, 173, 10.1016/S0168-8278(98)80001-9
Donato, 1998, A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma, Int J Cancer, 75, 347, 10.1002/(SICI)1097-0215(19980130)75:3<347::AID-IJC4>3.0.CO;2-2
1994
Kao, 2003, Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers, Gastroenterology, 124, 327, 10.1053/gast.2003.50053
Chu, 2003, Prevalence of HBV precore/core promoter variants in the United States, Hepatology, 38, 619, 10.1053/jhep.2003.50352
Henry, 2000, Foodborne disease and mycotoxin epidemiology, 593
Donato, 1997, Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case–control study in Italy. Brescia HCC study, Hepatology, 26, 579, 10.1002/hep.510260308
Kuper, 2000, Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma, Int J Cancer, 85, 498, 10.1002/(SICI)1097-0215(20000215)85:4<498::AID-IJC9>3.0.CO;2-F
Wang, 2003, Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan, Cancer Causes Control, 14, 241, 10.1023/A:1023636619477
Chen, 2003, Smoking and liver cancer in China: case–control comparison of 36,000 liver cancer deaths vs. 17,000 cirrhosis deaths, Int J Cancer, 107, 106, 10.1002/ijc.11342
La Vecchia, 1996, Oral contraceptives and cancer. A review of the evidence, Drug Saf, 14, 260, 10.2165/00002018-199614040-00006
Kew, 1990, Contraceptive steroids as a risk factor for hepatocellular carcinoma: a case/control study in South African black women, Hepatology, 11, 298, 10.1002/hep.1840110221
Mant, 1995, Trends in mortality from primary liver cancer in England and Wales 1975–92: influence of oral contraceptives, Br J Cancer, 72, 800, 10.1038/bjc.1995.415
Waetjen, 1996, Oral contraceptives and primary liver cancer: temporal trends in three countries, Obstet Gynecol, 88, 945, 10.1016/S0029-7844(96)00340-7
Beral, 1999, Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study, BMJ, 318, 96, 10.1136/bmj.318.7176.96
1997, Oral contraceptives and liver cancer. Results of the Multicentre International Liver Tumor Study (MILTS), Contraception, 56, 275
Yu, 2003, Role of reproductive factors in hepatocellular carcinoma: impact on hepatitis B- and C-related risk, Hepatology, 38, 1393
Lagiou, 2000, Role of diabetes mellitus in the etiology of hepatocellular carcinoma, J Natl Cancer Inst, 92, 1096, 10.1093/jnci/92.13.1096
Wideroff, 1997, Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark, J Natl Cancer Inst, 89, 1360, 10.1093/jnci/89.18.1360
Adami, 1996, Excess risk of primary liver cancer in patients with diabetes mellitus, J Natl Cancer Inst, 88, 1472, 10.1093/jnci/88.20.1472
El Serag, 2004, Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma, Gastroenterology, 126, 460, 10.1053/j.gastro.2003.10.065
Sorensen, 2003, Risk of cancer in patients hospitalized with fatty liver: a Danish cohort study, J Clin Gastroenterol, 36, 356, 10.1097/00004836-200304000-00015
Whittle, 1995, Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages, Lancet, 345, 1089, 10.1016/S0140-6736(95)90822-6
Hsu, 1988, Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3464 infants of hepatitis B surface antigen-carrier mothers, JAMA, 260, 2231, 10.1001/jama.1988.03410150079034
Chang, 1997, Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group, N Engl J Med, 336, 1855, 10.1056/NEJM199706263362602
Lee, 1998, Hepatitis B vaccination and reduced risk of primary liver cancer among male adults: a cohort study in Korea, Int J Epidemiol, 27, 316, 10.1093/ije/27.2.316